Levosulpiride
From Self-sufficiency
| Levosulpiride | |
|---|---|
| File:Levosulpiride.png | |
| N-[[(2S)-1-Ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
| CAS number | 23672-07-3 |
| PubChem | 688272 |
| SMILES | Script error: No such module "collapsible list". |
| style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
| Molecular formula | C15H23N3O4S |
| Molar mass | 341.43 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
A substituted benzamide anti-psychotic, reported to be a selective antagonist of central dopamine (D-2, D-3 and D-4) receptors, Levosulpiride is also calimed to have mood elevating properties. Levosulpiride is used in the treatment of psychoses, particularly negative symptoms of schizophrenia, anxiety disorders, dysthymia, vertigo, dyspepsia, irritable bowel syndrome and premature ejaculation.
In a dose range of 50-200 mg/day, Levosulpiride is therapeutic for negative and cognitive symptoms of schizophrenia, and for depressive and somatoform disorders.
Levosulpiride is an antipsychotic. It is the (S)-enantiomer of sulpiride.
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
